Health Ministry appoints 12 analysts pan India for different classes of drugs; Details

New Delhi: Through a recent Gazette notification, the Union Health Ministry has announced the appointment of Government Analysts in pan India in respect of different classes of drugs including therapeutic monoclonal antibody products, Blood Grouping Reagents, Vaccine products and others.

The Gazette dated November 26 2019, stated that the Central Government has appointed persons as government analysts for the whole of India in respect of different classes of drugs in exercise of the powers conferred by sub-section (2) of section 20 of the Drugs and Cosmetics Act, 1940 (23 of 1940) read with rule 44 of the Drugs and Cosmetics Rules, 1945.

A dozen personnel have been appointed as analysts including Scientists of Grade I, II, III- Dr Reba Chhabra, Dr Rajesh Kumar Sharma, Dr J P Prasad, Dr Meena Kumari, Madhu Erramilli, Kanchan Ahuja, Ajanta Sirkar, Dr Charu M Kamal, Gurminder Bindra, Subhash Chand, Harit Kasana, Jaipal Meena.

The class of drugs that will be analysed by the appointed analysts read- Human Immunodeficiency Virus, Hepatitis B Surface Antigen, Hepatitis C Virus, Human Immunodeficiency Virus, Hepatitis B Surface Antigen, Hepatitis C Virus, Human Albumin, Human Normal Immunoglobulin (Intramuscular and intravenous), Anti-Inhibitor Coagulation Complex, Glucose Test Strips; and Fully automated analyser based glucose reagent. Therapeutic Monoclonal Antibody Product such as Rituximab, Trastuzumab, Adalimumab, Bevacizumab have been included in the list.

The details as mentioned in the Gazette read;